Orthopedic Bone Cement And Casting Materials Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

Orthopedic bone cement is primarily used in joint replacement surgeries to anchor artificial joints to surrounding bone, while casting materials, including plaster of Paris and synthetic bandages, immobilize fractures during healing. PMMA-based cements account for the largest share of the market due to their long track record of mechanical reliability, though calcium-phosphate cements are increasingly adopted for their osteoconductive properties. The market also encompasses casting tapes, splints, and related consumables used in orthopedic and sports medicine settings.

• •PMMA (Polymethylmethacrylate) cements remain the dominant product type, used in over 90% of hip and knee replacement procedures globally.
• •Casting materials, including synthetic and traditional plaster bandages, represent a significant complementary segment alongside bone cements.
• •End-use applications span joint arthroplasty, vertebroplasty/kyphoplasty, trauma fixation, cranio-maxillofacial surgery, and dental implantology.

The market is propelled by a globally aging population experiencing higher rates of degenerative joint disease, leading to increased demand for hip, knee, and shoulder replacement surgeries. Rising prevalence of osteoporosis and road traffic accidents further elevates demand for fracture management and vertebral augmentation procedures. Expanding healthcare infrastructure in emerging economies and ongoing product innovations, such as antibiotic-loaded cements and low-viscosity formulations, are additional catalysts. Additionally, the growing trend toward minimally invasive and outpatient orthopedic surgeries supports procedural volume growth.

• •Antibiotic-loaded bone cements are increasingly preferred in revision surgeries and high-infection-risk joint replacements to reduce postoperative complications.
• •Osteoporotic fracture incidence is rising alongside aging demographics, boosting demand for vertebroplasty, kyphoplasty, and bone void filler products.
• •Advancements in bioactive and resorbable ceramic-based cements are expanding clinical adoption in spinal fusion and dental implant applications.

By material type, the market comprises PMMA, calcium-phosphate/ceramic cements, acrylic blends and copolymers, bio-glass, and other advanced materials, with PMMA holding the largest share. By application, key segments include joint replacement, fracture fixation, vertebroplasty, and dental/cranio-maxillofacial procedures. Regionally, North America leads the market, supported by high surgical volumes, advanced healthcare infrastructure, and favorable reimbursement environments, while Europe holds a strong and stable share. Asia-Pacific is the fastest-growing region, fueled by expanding access to orthopedic care, rising disposable incomes, and growing medical tourism in countries such as India, China, and South Korea.

• •North America accounts for the largest regional market share, driven by high hip and knee replacement procedure rates and established reimbursement frameworks.
• •Asia-Pacific is projected to register the highest growth rate, supported by aging populations, healthcare infrastructure expansion, and rising surgical adoption.
• •Calcium-phosphate and bioactive ceramic cements represent the fastest-growing material segment, though from a smaller base relative to PMMA.

What are the recent trends and outlook?

The market outlook through 2030 remains positive, with continued growth expected from rising orthopedic procedure volumes and incremental product innovation. Key trends include the shift toward injectable and low-viscosity bone cements that improve surgical precision, the integration of antibiotic and anti-resorptive agents into cement formulations, and growing clinical interest in resorbable ceramic cements that eliminate long-term implant retention. Value-based procurement and healthcare cost containment may exert some pricing pressure, particularly in price-sensitive markets. Overall, the combination of demographic tailwinds, technological progress, and expanding surgical indications supports a steady growth trajectory over the forecast period.

• •The market is expected to reach approximately $3.1-3.3 billion by 2030 at a 6.4% CAGR, with vertebroplasty and cement-augmented screw fixation driving above-average growth.
• •Antibiotic-eluting and chemically modified bone cements are a key innovation area aimed at reducing periprosthetic joint infections, a major clinical and economic concern.
• •The Asia-Pacific region is anticipated to increasingly outpace developed markets in volume growth, with China, India, and Southeast Asia as key contributors.